For more than 100 years, veterinarians have been forced to rely on slow and unreliable traditional culturing diagnostics of the past, whereas human diagnostic technology has taken a giant step forward. MicroGen Vet is here to change that. We will bring DNA-based Next Generation Sequencing (NGS) diagnostics to the veterinary marketplace as the exclusive reseller of MicroGen DX diagnostic services.
MicroGen DX is the market leader in providing this cutting edge technology to the human diagnostics market - with over 9 years in operation and 300K tests run on human patients. (Source) Now, it's time for veterinarians to benefit from this technology. We bring accurate, quick, and affordable NGS testing services directly from MicroGen DX's laboratories, meaning we're able to immediately fold into the already high volume of human tests, keeping costs low.
We're the exclusive reseller of this technology that is changing the way vets diagnose their patients. As the understanding of biofilms grows, the need for accurate identification of all microbes in an infection is becoming more and more critical. Veterinary Research Universities have already begun to research the many advantages of this technology.
In fact, MicroGen Vet is already supporting clinical trials on over 200 horses with both the Rood & Riddle Equine Hospital and Colorado State University's Equine Reproductive Laboratory. Our plan is to make inroads in the U.S. equine and small-animal markets, and then expand to exotic/zoo and livestock markets, and then to grow into international veterinary markets for each.
Investment
$9.00/Class B Unit│When you invest you are betting MicroGen Vet's future value will exceed $5.7M.
For details on the bonus, please see the Offering Summary below.
We're the exclusive reseller of Next Generation Sequencing services from the leader in human healthcare: MicroGen DX. This technology is already proven to work with humans: with over 300K tests run to date. And, we believe, growth in the veterinary market will be rapid due to industry purchasing standards and more limited impact of regulations for billing and healthcare in the world of veterinary medicine.
We're bringing cutting edge technology to the veterinary marketplace, which has been stagnant in the use of traditional culturing for over 100 years. Culturing in this market is ineffective and far out of date given today's DNA-based diagnostic capabilities.
*National Institutes of Health
*J.W. Costerton,
Center For Genomic Sciences
*Dr. Michael Walters, DO
Urologist, Foley AL
*Centers for Disease Control
Dr. Bimbo Welker
Director of Ohio State Large Animal Services
A Level 1 PCR panel report is provided to customer within 24 hrs. It identifies bacteria load, presence of common microbes & antibiotic resistance genes.
The Level 2 NGS report is provided to customer within 3-4 days. It identifies every microbe present, along with a list of common antibiotics used for identified microbes.
We're able to keep costs low by merging with the high volume of MicroGen DX tests through the same laboratories (DNA is DNA)
To understand how NGS is changing the veterinary marketplace, you need only look at how far advanced it is compared to traditional culturing, which dominates diagnostic testing still used across the country by vets today. NGS technology is far superior, and we believe it will change the industry.
Chronic infections and biofilm education will initially be the focus of the business. We believe that the Total Attainable Market for sales of NGS services is estimated at:
Currently, we are focused initially on equine and small-animal markets but have already received significant interest from national zoos and livestock practitioners. Additionally, we have been contacted by potential partners in Latin America and Canada, which represent significant expansion opportunities in 2019 and beyond.
*Our best estimates of market size and characteristics based on American Veterinary Medical Association (AVMA) and other industry sources.
Join us in bringing this cutting-edge technology to the world of veterinary health.
We've already got an amazing and proven product on our hands, which means the next step is to simply distribute it to a marketplace that will benefit from it greatly. Your investment dollars will primarily go toward fueling market education efforts and for building amazing regional sales teams to drive growth through our business partners.
A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.
We certainly hope to see many of those following MicroGen Vet on StartEngine convert to investors this week as Friday is our last day on the platform. Don't miss your opportunity to participate!
Thanks everyone for your consideration!
MicroGen Vet and NGS has been received warmly and with great interest by many top veterinary research universities – multiple visits and talks planned for the Fall
Clinical Trials interest growing rapidly with multiple planned for this Fall
Services have been picked up my multiple leading distribution and resale partners
Branding and market reach
Expanding clinical support network
Expanding sales support network
Funding plan still in process
We need your support to provide short term funding in order to continue our push for market education and for recruitment of additional sales support resources to support our distribution partners. We also plan to participate in several trade shows including AAEP and VMX. Your investment will support MicroGen Vet as we continue to implement our business model while we secure significant funding for growth through 2019. Don’t miss this opportunity to participate – it won’t come again!!! We want folks who are passionate about animal health to join our journey!!!
[The following is an automated notice from the StartEngine team].
Hello!
As you might know, MicroGen Vet has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in MicroGen Vet be on the lookout for an email that describes more about the disbursement process.
This campaign will continue to accept investments until its indicated closing date.
Thanks for funding the future.
-StartEngine
[The following is an automated notice from the StartEngine team].
Hello!
As you might know, MicroGen Vet has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in MicroGen Vet be on the lookout for an email that describes more about the disbursement process.
This campaign will continue to accept investments until its indicated closing date.
Thanks for funding the future.
-StartEngine
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}